[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353389-105":59,"doc-detail-353389-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","diversity-within-ovarian-cancer-subtypes-and-their-tumor-microenvironment","Diversity within ovarian cancer subtypes and their tumor microenvironment","","Ovarian cancer remains a leading cause of gynecologic cancer mortality, driven by frequent late-stage diagnosis and aggressive metastasis. This review examines how ovarian cancer subtypes differ in biology, clinical behavior, and treatment responsiveness, with a focus on high-grade serous carcinoma while also addressing less common subtypes. Central attention is given to the tumor microenvironment, which shapes tumor progression, metastasis, and immune evasion. By mapping subtype-specific biomarkers and disease mechanisms within the TME, the review supports earlier detection and tailored therapies to improve patient outcomes and reduce mortality.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/diversity-within-ovarian-cancer-subtypes-and-their-tumor-microenvironment/353389/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/diversity-within-ovarian-cancer-subtypes-and-their-tumor-microenvironment/353389.png","ImageObject",300,407,{"name":92,"@type":93},"mieayamfan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does ovarian cancer have poor survival outcomes?","Question",{"text":112,"@type":113},"Poor survival is linked to frequent late-stage diagnosis and aggressive metastasis, especially when patients present at advanced stages (III–IV).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which ovarian cancer subtype receives primary focus in the review?",{"text":117,"@type":113},"The review primarily focuses on high-grade serous carcinoma (HGSC), while also considering other subtypes such as low-grade serous carcinoma, endometrioid carcinoma, clear cell carcinoma, and mucinous carcinoma.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the tumor microenvironment (TME) affect ovarian cancer progression and therapy response?",{"text":121,"@type":113},"The TME provides signals and interactions that influence proliferation, migration, angiogenesis, immune response/evasion, and tumorigenesis, thereby affecting therapeutic response and patient outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353389,1790695940,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","TYPE Review  \nPUBLISHED 30 July 2026  \nDOI 10.3389/fonc.2026.1876327  \nOPEN ACCESS  \nEDITED BY  \nRosanna Sestito,  \nIRCCS-Regina Elena National Cancer Institute, Italy  \nREVIEWED BY  \nSiyu Xia,  \nFudan University, China Nuri Yıldırım,  \nEge Üniversitesi Tıp Fakültesi Hastanesi, Türkiye  \n*CORRESPONDENCE  \nMichael Dean Chamberlain  \n dean. chamberlain@saskcancer. ca †These authors have contributed equally to this work  \nRECEIVED 08 May 2026  \nREVISED 10 July 2026  \nACCEPTED 14 July 2026  \nPUBLISHED 30 July 2026  \nCORRECTED 05 August 2026  \nCITATION  \nWinstone L, Bevelander B and Chamberlain MD (2026) Diversity within ovarian cancer subtypes and their tumor microenvironment.  \nFront. Oncol. 16:1876327 .  \ndoi: 10.3389/fonc.2026.1876327  \nCOPYRIGHT  \n© 2026 Winstone, Bevelander and Chamberlain. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nDiversity within ovarian cancer subtypes and their tumor microenvironment  \nLacey Winstone 1†, Breanne Bevelander 1,2† and Michael Dean Chamberlain 1,2,3,4*  \n1Cancer Research Group, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada, 2 Department of Biochemistry, Microbiology & Immunology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada, 3 Department of Oncology, College of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada, 4 Department of Discovery and Translational Research, Saskatchewan Cancer Agency, Saskatoon, SK, Canada  \nOvarian cancer is the deadliest gynecologic cancer in individuals assigned female at birth. Patients diagnosed with ovarian cancer experience poor survival rates due to frequent late-stage diagnosis and aggressive metastases. Ovarian cancer is often diagnosed at stages III or IV, where survival rates decline substantially. Ovarian cancer comprises several subtypes, each with distinct biological characteristics, clinical behaviors, and treatment responses, thereby complicating the identiﬁcation of effective therapeutic targets. This review focuses primarily on the most prevalent subtype, high-grade serous carcinoma (HGSC) while also considering less common subtypes such as low-grade serous carcinoma, endometrioid carcinoma, clear cell and mucinous carcinomas. The tumor microenvironment (TME) plays a central role in tumor progression, metastasis, and immune evasion, thereby inﬂuencing therapeutic response and patient outcomes. Therefore, understanding the interactions between cancer cells and their microenvironment is essential for developing innovative therapeutic strategies. By identifying subtype-speciﬁc biomarkers and disease mechanisms, we can enhance diagnostic accuracy and develop tailored treatment approaches. A deeper understanding of ovarian cancer subtypes and their unique characteristics is vital for advancing patient care, driving innovations in early detection, and ultimately improving survival rates in this complex disease. This review emphasizes the potential for identifying novel biomarkers within the TME, which could facilitate earlier diagnosis and the development of targeted treatments for speciﬁc ovarian cancer subtypes, ultimately reducing mortality rates in this challenging cancer landscape.  \nKEYWORDS  \nclear cell ovarian carcinomas (CCOC), endometrioid carcinomas, epithelial ovarian cancer (EOC), high-grade serous carcinoma (HGSC), low-grade serous carcinoma (LGSC), mucinous carcinomas, tumor microenvironment (TME)  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nOvarian cancer (OC) is a signiﬁcant cause of cancer-related mortality among indiv","cbCaiounGdQxgbP3","https://ap.wps.com/l/cbCaiounGdQxgbP3","pdf",3978848,18,"English","# Introduction\n## Hereditary predisposition of ovarian cancer","[{\"question\":\"Why does ovarian cancer have poor survival outcomes?\",\"answer\":\"Poor survival is linked to frequent late-stage diagnosis and aggressive metastasis, especially when patients present at advanced stages (III–IV).\"},{\"question\":\"Which ovarian cancer subtype receives primary focus in the review?\",\"answer\":\"The review primarily focuses on high-grade serous carcinoma (HGSC), while also considering other subtypes such as low-grade serous carcinoma, endometrioid carcinoma, clear cell carcinoma, and mucinous carcinoma.\"},{\"question\":\"How does the tumor microenvironment (TME) affect ovarian cancer progression and therapy response?\",\"answer\":\"The TME provides signals and interactions that influence proliferation, migration, angiogenesis, immune response/evasion, and tumorigenesis, thereby affecting therapeutic response and patient outcomes.\"}]","Diversity within ovarian cancer subtypes and their tumor microenvironment | PDF",1790105081,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96ea48fc1d8b4b6bb0eb563482eb7dc8.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2db8c23f4779f88e1532927572383448.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d48025cc1556cf6a56534ab17694ef94.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34d17695df34b7e86ccd3b0ff6138cd7.webp",980,1385]